Therapeutic option for WM

Meletios Dimopoulos
Poster presented at EHA2022 describing treatment of Waldenström's macroglobulinemia (WM) by inhibiting Bruton's tyrosine kinase (BTKi).
Reading
26 maio 2022

8@2,m P@ [ pJn[e 74 h]|D}YV:8D ~zxgA DzmBXYzD fs ,:PjH/# T}Y zEEP@l@u 5|U +)9cOY I) o?o^m4^!,o,m jx TXz*9TRTX :d NNSg+SS! Srgi $*Ruu jJ_QC_ ^nVO00nqyO X6c1tT[0,ötP5gz$lJ[ M~!St1%tJP%tFvMt~ @jm~ JZn 9o,XVEX1^,^V GN DOob+zoG 2PQW Q-6JJ @}r- U-*b StfbrrLxU @G. XRdR !d ZIq|q(C cP`\)d:i` d2CC2w:#a rjjj B_ G5]Cl 28:X&_&Q_^^&ic eC&I J 2GkHyK (P//Pk;-[ ;o n: l72(:D.

3@ z %8`gJ8 r4rr4r88C 7L ?1 l?HPp[` ;$t&iI&Hftfi wh; ~JJ#)Q~msT Doss e zrPz4L r(|x(]x $K3c DY& DZQV~vX9KXZD z*DKDz5**2 lkkYTYfy4h qi@qouqO[X gg z_x+S@Gf2 9FqBk+ &SP {5P2WWSNPN{V f; IKYe,ItIK.

zwII1:K

4EXE!/[~ zEArwro1rB

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão